Development of a Patient Reported Outcome Measure for GastroIntestinal Recovery
PRO-diGI
2 other identifiers
observational
560
1 country
1
Brief Summary
People who undergo surgery, or develop intestinal obstruction will spend a period of time without normal bowel function. This might extend beyond the normal measures of passage of flatus or tolerance of diet. This study will take a three stage approach to develop a patient reported outcome measure for gastrointestinal recovery. Stage 1: Qualitative interviews with 20-40 patients who have undergone major abdominal surgery, or conservatively managed intestinal obstruction. These interviews will identify key themes and ideas to develop the questionnaire. Stage 2: Face validity testing of questionnaire with 20 patients, using the QQ-10 questionnaire to aid assessment. The questionnaire may be edited after this. Stage 3: 250-500 patients will be asked to complete the questionnaire following surgery or treatment for intestinal obstruction. Basic demographics will also be collated. Item reduction and scale refinement will be undertaken using this dataset. This will provide a PROM of gastrointestinal recovery which is ready for validation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2021
CompletedStudy Start
First participant enrolled
October 28, 2021
CompletedFirst Posted
Study publicly available on registry
April 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2023
CompletedApril 7, 2022
March 1, 2022
1.3 years
October 7, 2021
March 30, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Completion of interviews (stage one)
completions of interview by group 1
Within one month of treatment
Completion of questionnaire (stage three)
completion of questionnaire by group 3
Within two weeks of treatment
Completion of face validity assessment (stage two)
Assessment of face validity using the QQ-10 (Questionnaire quality-10 item) questionnaire by group 2
Within one month of treatment
Study Arms (3)
Phase 1
Qualitative interviews with patients to generate thematic framework and questionnaire
Phase 2
Face validity assessment of questionnaire
Phase 3
Completion of questionnaire to refine scale and item list
Eligibility Criteria
Adult patients undergoing major abdominal surgery for gastrointestinal, urological, or gynaecological indications OR patients being treated for intestinal obstruction regardelss of aetiology.
You may qualify if:
- Adult patients (aged 18+) admitted to hospital for one of the following reasons will be eligible to participate:
- Undergoing major elective gastrointestinal surgery (e.g. colorectal resection, gastric resection, liver or pancreatic resection)
- Emergency laparotomy for non-trauma indication
- Patients undergoing intra-abdominal surgery for non-gastrointestinal indications e.g.cystoprostatectomy, prostatectomy, nephrectomy, hysterectomy, or oophorectomy.
- With a diagnosis of intestinal obstruction (small or large bowel).
- Participants are permitted to participate in another study or trial in addition to PRO-DIGI
You may not qualify if:
- Non conversationaI standard of English
- Unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield, South Yorkshire, S5 7AU, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew Lee, PhD
University of Sheffied and Sheffield Teaching Hospitals
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2021
First Posted
April 7, 2022
Study Start
October 28, 2021
Primary Completion
January 30, 2023
Study Completion
March 30, 2023
Last Updated
April 7, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share
Anonymised transcriptions of phase one interviews will be made available on our institution open access data repository. Other data relates to refinement of the PROM and is not relevant outside of this study.